HAEK.DE
Price:
$21.4
Market Cap:
$111.50M
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its generic drugs. It provides pharmaceuticals in the areas of oncology, HIV, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic medicine, as well as cosmetic products. The company also develops and markets medical devices and medical technology products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors, clinics, and medical laboratories. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2007-12-28
Stock Exchange
XETRA
Ticker
HAEK.DE
According to Haemato AG’s latest financial reports and current stock price. The company's current Enterprise Value is 93.05M. This represents a change of -4.38% compared to the average of 97.32M of the last 4 quarters.
The mean historical Enterprise Value of Haemato AG over the last ten years is 116.67M. The current 93.05M Enterprise Value has changed 7.88% with respect to the historical average. Over the past ten years (40 quarters), HAEK.DE's Enterprise Value was at its highest in in the June 2017 quarter at 157.91M. The Enterprise Value was at its lowest in in the June 2007 quarter at 0.
Average
116.67M
Median
117.71M
Minimum
67.00M
Maximum
150.88M
Discovering the peaks and valleys of Haemato AG Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 243.77%
Maximum Annual Enterprise Value = 150.88M
Minimum Annual Increase = -41.57%
Minimum Annual Enterprise Value = 67.00M
| Year | Enterprise Value | Change |
|---|---|---|
| 2022 | 67.00M | -41.57% |
| 2021 | 114.66M | -5.04% |
| 2020 | 120.75M | 26.42% |
| 2019 | 95.51M | -22.29% |
| 2018 | 122.90M | -9.99% |
| 2017 | 136.55M | -9.50% |
| 2016 | 150.88M | 12.82% |
| 2015 | 133.73M | 17.52% |
| 2014 | 113.79M | 2.62% |
| 2013 | 110.89M | 243.77% |
The current Enterprise Value of Haemato AG (HAEK.DE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
100.80M
5-year avg
104.17M
10-year avg
116.67M
Haemato AG’s Enterprise Value is greater than InflaRx N.V. (51.78M), greater than YourWay Cannabis Brands Inc. (3.28M), less than Aurora Cannabis Inc. (353.80M), less than 4SC AG (145.48M), greater than Biofrontera AG (6.69M), greater than Paion AG (12.43M), greater than BZAM Ltd. (40.04M), greater than High Fusion Inc. (0), greater than Molecule Holdings Inc. (5.60M), less than PharmaSGP Holding SE (305.40M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 51.78M | $129.91M | |
| 3.28M | $17.00M | |
| 353.80M | $19.64M | |
| 145.48M | $150.70M | |
| 6.69M | $20.67M | |
| 12.43M | $2.71M | |
| 40.04M | $4.52M | |
| 0 | $1.08M | |
| 5.60M | $329.85K | |
| 305.40M | $333.86M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Haemato AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Haemato AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Haemato AG's Enterprise Value?
What is the highest Enterprise Value for Haemato AG (HAEK.DE)?
What is the 3-year average Enterprise Value for Haemato AG (HAEK.DE)?
What is the 5-year average Enterprise Value for Haemato AG (HAEK.DE)?
How does the current Enterprise Value for Haemato AG (HAEK.DE) compare to its historical average?